Prakt. lékáren. 2012; 8(2): 76-79

Pharmaceutical care of oncologic patients - adverse effects I.

Jindřiška Hofmanová
Nemocniční lékárna, FN Hradec Králové

Oncologic therapy is connected with a number of adverse effects, but it is possible to deal with these effects, moderate their symptoms

and at best prevent them. It is important to inform a patient about the adverse effects of the used therapy and the possibilities of pharmacologic

and nonpharmacologic precautions and ways of prevention. That is just a great opportunity and chance for pharmacists or

pharmaceutical assistants.

Keywords: adverse effects, oncologic therapy, oncologic patient, pharmaceutical care

Published: April 23, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hofmanová J. Pharmaceutical care of oncologic patients - adverse effects I. Praktické lékárenství. 2012;8(2):76-79.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Sláma O, Kabelka L, Vorlíček J, a kol. Paliativní medicína pro praxi. Galén 2007: 164-167.
    2. Hercová K. Mukozitida dutiny ústní při radioterapii v oblasti hlavy a krku. Onkologie 2009; 2: 127-128.
    3. Hynková L, Doležalová H. Nežádoucí účinky radioterapie a podpůrná léčba u radioterapie nádorů hlavy a krku. Onkologie 2008; 2: 88-90.
    4. Tomíška M. Současné přístupy k prevenci a léčbě nevolnosti a zvracení při chemoterapii. Farmakoterapie 2011; 2: 201-208.
    5. Adam Z, Vorlíček J, Koptíková J. Obecná onkologie a podpůrná léčba. Grada Publishing 2003: 557-564.
    6. Vyzula R, a kol. Zásady cytostatické léčby maligních onkologických onemocnění - Zásady prevence a léčby nevolnosti a zvracení po protinádorové léčbě. Masarykův onkologický ústav 2011: 139-143. http://www.linkos.cz/informace-pro-praxi/zasady-cytostaticke-lecby/26-zasady-prevence-a-lecbynevolnosti-a-zvraceni-po-protinadorove-lecbe/.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.